Third-Party Hardware Modification of Interventional X-Ray Equipment
The new AdvaMed Imaging technical white paper outlines concerns with third-party modification of interventional X-ray equipment, which can pose unforeseen risks for patients and providers. The white paper further calls for a complete technical assessment before using any third-party modification to mitigate potential harm.
This report provides our recommendations to regulators and other policy makers and stakeholders regarding third-party hardware modifications. Download the full white paper here.
Related Reading
News / Medical Imaging
AdvaMed Releases White Paper Addressing Considerations of Third-Party Hardware Modification of Interventional X-Ray Equipment
November 26, 2024
AdvaMed, the Medtech Association, recently published a technical white paper outlining concerns with third-party modification of interventional X-ray equipment, which can pose unforeseen risks for patients and providers.
News / Coverage & Payment / Medical Imaging
AdvaMed Calls on Medicare to Cover Supplemental Imaging as Part of Breast Cancer Screening
November 4, 2024
AdvaMed, the Medtech Association, called on Medicare in a letter sent Friday to cover supplemental imaging for women with heterogeneously and extremely dense breast tissue, noting the life-saving value of the additional screening and the pressing health equity needs Medicare coverage of these critical services would address.
News / Medical Imaging
AdvaMed Achieves National Accreditor’s Endorsement to Develop Medical Device Standards
September 4, 2024
AdvaMed, the Medtech Association, announced today that it has received accreditation from the premier American National Standards Institute (ANSI) to develop industry standards for medical device innovation. As an ANSI-accredited organization, AdvaMed will begin by developing standards for medical imaging technologies, including applications important to all of medtech, such as cyber security and artificial intelligence.
Blog / Medical Imaging
Letter to the Editor: Expand Access to Focused Ultrasound
August 29, 2024
Years ago, my life was turned upside-down by an essential tremor, which caused my hand to shake so
severely that I had to leave my career as a nurse practitioner with the Department of Veterans Affairs.
Blog / Government & Legislative Affairs / Medical Imaging
AdvaMed and Right Scan Right Time Host Successful Patient Fly-In Advocating for Increased Access to AI Cancer Screenings
August 19, 2024
In July, five patient leaders traveled to Capitol Hill to share their personal stories and speak to their lawmakers about the need to expand access to artificial intelligence technologies for medical imaging. The fly-in was held by Right Scan Right Time, a patient platform supported by AdvaMed Imaging.
Blog / Government & Legislative Affairs / Medical Imaging
AdvaMed Hosts Demo Day Showcasing Innovative AI Imaging Technologies for Congressional Staff
August 13, 2024
AdvaMed recently hosted an “AI Demo Day” on Capitol Hill, where a number of medical imaging innovators had the opportunity to showcase some of the latest artificial intelligence (AI) technologies to members of Congress and their staff.
Blog / Government & Legislative Affairs / Medical Imaging
Labor-HHS Appropriations Report Shows Progress for Patients
July 18, 2024
The recent House Departments of Labor and Health and Human Services Appropriations report has important news highlighting continued momentum in Congress to improve patient access to innovative medical imaging technologies and evidencing that AdvaMed’s messaging and advocacy initiatives are resonating in Congress.
News / Coverage & Payment / Medical Imaging
AdvaMed Applauds Bipartisan Senate Letter Urging CMS to Establish a Reimbursement Pathway for AI-Enabled Medical Devices
June 13, 2024
This week, AdvaMed, the Medtech Association, applauded a bipartisan group of Senators for urging the Centers for Medicare & Medicaid Services (CMS) to develop a formalized payment pathway for algorithm-based health care services (ABHS) in the upcoming Hospital Outpatient Prospective Payment Systems (HOPPS) rulemaking cycle. ABHS are FDA-cleared medical devices that rely on artificial intelligence (AI) and machine learning (ML) to produce clinical information to aid in patient diagnosis or treatment.